doxorubicinol

(1S,3S)-3-[(1S)-1,2-dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside

NKZRZOVSJNSBFR-FEMMEMONSA-N CHEBI:133817 3 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

3 Reactome pathways

Metabolite details

Identifier: NKZRZOVSJNSBFR-FEMMEMONSA-N
InChI Key: NKZRZOVSJNSBFR-FEMMEMONSA-N
IUPAC name: (1S,3S)-3-[(1S)-1,2-dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
Preferred name: doxorubicinol
INN name: —
Synonym: 13-dihydrodoxorubicin
ChEBI: CHEBI:133817

Reactome pathways

R-HSA-1430728 - Metabolism
R-HSA-211859 - Biological oxidations
R-HSA-211945 - Phase I - Functionalization of compounds

Observed in studies

Observed in differential profiles